GlassScriptPhysician profile
Mark Dziemianowicz
NPI 1154776029
$1,061.04
in general payments reported to CMS, 2019-2025
16 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.87 · 2022: $199 · 2023: $188 · 2024: $168 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $282.85 | 2022-2025 | Varian Ethos Treatment Planning, Bravos Afterloader System, Somatom Go.Top |
| Elekta, INC. | $171.30 | 2023-2025 | Flexitron Hdr, Elekta Medical Linear Accelerator |
| Icotec Medical INC. | $129.58 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Medtronic, INC. | $82.34 | 2025 | Osteocool Rf Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $78.30 | 2021-2023 | |
| Celgene Corporation | $57.78 | 2023-2024 | Reblozyl |
| Novocure INC. | $45.45 | 2022 | |
| Sumitomo Pharma America, INC. | $45.11 | 2023 | Orgovyx |
| Janssen Scientific Affairs, LLC | $35.75 | 2022 | |
| Ge Healthcare | $34.62 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $21.62 | 2022 | |
| Zap Surgical Systems, INC. | $17.25 | 2021 | |
| Boston Scientific Corporation | $15.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.55 | 2023 | |
| Myovant Sciences INC. | $15.10 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dziemianowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.